These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia. Quintarelli C; Dotti G; De Angelis B; Hoyos V; Mims M; Luciano L; Heslop HE; Rooney CM; Pane F; Savoldo B Blood; 2008 Sep; 112(5):1876-85. PubMed ID: 18591381 [TBL] [Abstract][Full Text] [Related]
23. Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma. Colleoni GW; Capodieci P; Tickoo S; Cossman J; Filippa DA; Ladanyi M Hum Pathol; 2002 May; 33(5):496-502. PubMed ID: 12094374 [TBL] [Abstract][Full Text] [Related]
24. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Nair SK; Morse M; Boczkowski D; Cumming RI; Vasovic L; Gilboa E; Lyerly HK Ann Surg; 2002 Apr; 235(4):540-9. PubMed ID: 11923611 [TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes. Ramadan G Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679 [TBL] [Abstract][Full Text] [Related]
26. Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes. Liao X; Li Y; Bonini C; Nair S; Gilboa E; Greenberg PD; Yee C Mol Ther; 2004 May; 9(5):757-64. PubMed ID: 15120337 [TBL] [Abstract][Full Text] [Related]
27. Knock-down of PRAME increases retinoic acid signaling and cytotoxic drug sensitivity of Hodgkin lymphoma cells. Kewitz S; Staege MS PLoS One; 2013; 8(2):e55897. PubMed ID: 23409080 [TBL] [Abstract][Full Text] [Related]
28. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha. Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527 [TBL] [Abstract][Full Text] [Related]
29. Dendritic cells restore CD8+ T cell reactivity to autologous HIV-1. Smith KN; Mailliard RB; Larsen BB; Wong K; Gupta P; Mullins JI; Rinaldo CR J Virol; 2014 Sep; 88(17):9976-90. PubMed ID: 24942586 [TBL] [Abstract][Full Text] [Related]
30. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs. Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362 [TBL] [Abstract][Full Text] [Related]
31. NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. Pollack SM; Li Y; Blaisdell MJ; Farrar EA; Chou J; Hoch BL; Loggers ET; Rodler E; Eary JF; Conrad EU; Jones RL; Yee C PLoS One; 2012; 7(2):e32165. PubMed ID: 22384167 [TBL] [Abstract][Full Text] [Related]
32. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses. Zhu F; Ramadan G; Davies B; Margolis DA; Keever-Taylor CA Clin Exp Immunol; 2008 Feb; 151(2):284-96. PubMed ID: 18005260 [TBL] [Abstract][Full Text] [Related]
33. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients. Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169 [TBL] [Abstract][Full Text] [Related]
34. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV+ Hodgkin's disease. Sing AP; Ambinder RF; Hong DJ; Jensen M; Batten W; Petersdorf E; Greenberg PD Blood; 1997 Mar; 89(6):1978-86. PubMed ID: 9058719 [TBL] [Abstract][Full Text] [Related]
35. [Construction of recombinant adenoviral vector containing gene of EWS-FLI1 and antitumor immunity of its modified dentritic cell in vitro]. Qu HY; Guo W; He XJ Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 38(6):623-7. PubMed ID: 17173084 [TBL] [Abstract][Full Text] [Related]
36. Impact of transfection with total RNA of K562 cells upon antigen presenting, maturation, and function of human dendritic cells from peripheral blood mononuclear cells. Gao L; Fan HH; Lu HZ; Nie XX; Liu Y; Yang YM; Qian KC; Gao F Transfusion; 2007 Feb; 47(2):256-65. PubMed ID: 17302772 [TBL] [Abstract][Full Text] [Related]
37. Calreticulin acts as an adjuvant to promote dendritic cell maturation and enhances antigen-specific cytotoxic T lymphocyte responses against non-small cell lung cancer cells. Liu X; Li J; Liu Y; Ding J; Tong Z; Liu Y; Zhou Y; Liu Y Cell Immunol; 2016 Feb; 300():46-53. PubMed ID: 26702740 [TBL] [Abstract][Full Text] [Related]
38. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro. Cai YG; Fang DC; Chen L; Tang XD; Chen T; Yu ST; Luo YH; Xiong Z; Wang DX; Yang SM Tumour Biol; 2007; 28(4):238-46. PubMed ID: 17717429 [TBL] [Abstract][Full Text] [Related]
39. Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs. Sohn DH; Sohn HJ; Lee HJ; Lee SD; Kim S; Hyun SJ; Cho HI; Cho SG; Lee SK; Kim TG PLoS One; 2015; 10(5):e0127899. PubMed ID: 26023769 [TBL] [Abstract][Full Text] [Related]
40. A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells. Wagner HJ; Bollard CM; Vigouroux S; Huls MH; Anderson R; Prentice HG; Brenner MK; Heslop HE; Rooney CM Cancer Gene Ther; 2004 Feb; 11(2):81-91. PubMed ID: 14685154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]